Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oesophageal Cancer Nos”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01851928
What this trial is testing

Validation of a Nutrition Screening Tool

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionCervical CancerEndometrial Cancer+7 more
Royal Marsden NHS Foundation Trust 128
Not applicableStudy completedNCT00629265
What this trial is testing

Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients

Who this might be right for
Dysphagia
Boston Medical Center 170
Early research (Phase 1)Active Not RecruitingNCT04460937
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

Who this might be right for
Clinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+56 more
National Cancer Institute (NCI)
Post-approval studies (Phase 4)Temporarily pausedNCT02366819
What this trial is testing

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Who this might be right for
Esophageal AdenocarcinomaGastric AdenocarcinomaStage IIB Gastric Cancer+6 more
University of Chicago 36
Not applicableStudy completedNCT03066167
What this trial is testing

Validation of Instruments Used for Assessment of Dysphagia in Patients With Esophageal Cancer

Who this might be right for
Dysphagia, EsophagealEsophageal Cancer
Vastra Gotaland Region 64
Testing effectiveness (Phase 2)UnknownNCT01693432
What this trial is testing

Docetaxel and S-1 for Advanced Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
Hallym University Medical Center 37
Testing effectiveness (Phase 2)Ended earlyNCT00183807
What this trial is testing

Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
University of Southern California 6
Large-scale testing (Phase 3)Study completedNCT02459457
What this trial is testing

A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer

Who this might be right for
Stage III Esophageal Squamous Cell Carcinoma
Fudan University 321
Early research (Phase 1)Ended earlyNCT05861947
What this trial is testing

Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies

Who this might be right for
RelapseAdvanced Malignant NeoplasmNon Small Cell Lung Cancer+5 more
Aurigene Discovery Technologies Limited 21
Early research (Phase 1)Not Yet RecruitingNCT06735638
What this trial is testing

Outside the Cage (OTC) Robotic Esophagectomy

Who this might be right for
Esophageal Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 31
Not applicableNot Yet RecruitingNCT07206589
What this trial is testing

Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial

Who this might be right for
Barrett EsophagusEsophageal Adenocarcinoma
Mayo Clinic 1,010
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117
What this trial is testing

Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

Who this might be right for
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc. 329
Large-scale testing (Phase 3)UnknownNCT01054274
What this trial is testing

A Multicentric Randomized Controlled Trial of Self-Expandable Esophageal Radiation Stent

Who this might be right for
Esophageal Cancer
Southeast University, China 180
Not applicableUnknownNCT04673968
What this trial is testing

Prehabilitation on Fitness, Surgical Outcomes and Mitochondria Functionality in Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Chang Gung Memorial Hospital 160
Testing effectiveness (Phase 2)Study completedNCT01522768
What this trial is testing

Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center 42
Very early researchStudy completedNCT00757549
What this trial is testing

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

Who this might be right for
Head and Neck Cancer
Mayo Clinic 30
Early research (Phase 1)Looking for participantsNCT07544589
What this trial is testing

Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

Who this might be right for
Colorectal CancerGastric AdenocarcinomaEsophageal Adenocarcinoma+1 more
Dispatch Biotherapeutics 66
Early research (Phase 1)Study completedNCT04316689
What this trial is testing

First-in-human Study of S-588210 (S-488210+S-488211)

Who this might be right for
Lung CancerHead and Neck CancerBladder Cancer+2 more
Shionogi 10
Not applicableStudy completedNCT00580138
What this trial is testing

Real-Time Internet Evaluation of Swallowing

Who this might be right for
Head and Neck CancerStroke
University of Arkansas 30
Testing effectiveness (Phase 2)Ended earlyNCT00539617
What this trial is testing

Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Esophageal Cancer
University of California, San Francisco 7
Next Page
4